BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 7254147)

  • 21. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isoenzymes of fructose phosphate aldolase in patients with progressive muscular dystrophy].
    Dikow AL; Tschankow IA; Samardshiew AC
    Z Klin Chem Klin Biochem; 1968 Sep; 6(5):391-3. PubMed ID: 5724312
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical and histopathological studies of the carrier state in Duchenne's muscular dystrophy.
    Ionasescu V; Vuia O; Luca N; Popa P
    Confin Neurol; 1968; 30(5):289-300. PubMed ID: 4891427
    [No Abstract]   [Full Text] [Related]  

  • 24. Duchenne muscular dystrophy: comparison among different racial groups.
    Bortolini ER; Zatz M
    Am J Med Genet; 1987 Dec; 28(4):925-9. PubMed ID: 3688030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum enzymatic activity in neuromuscular diseases].
    Strumień M
    Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum pyruvate kinase (PK) in the diagnosis of neuromuscular diseases].
    Chen Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):338-41. PubMed ID: 3836824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in the activity of blood serum enzymes in relatives of children with myopathy].
    Grinio LP
    Vopr Med Khim; 1966; 12(6):600-3. PubMed ID: 6000902
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigation on genetic heterogeneity in Duchenne muscular dystrophy.
    Rabbi-Bortolini E; Zatz M
    Am J Med Genet; 1986 May; 24(1):111-7. PubMed ID: 3706399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 31. [A study on the serum biochemistry in carrier detection of Duchenne muscular dystrophy].
    Xie B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):165-8, 189. PubMed ID: 1889329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum enzyme lowering and other effects of diethylstilbestrol (DIES) in Duchenne's muscular dystrophy (DMD).
    Cohen L; Morgan J; Schulman S; Lawrence A
    J Lab Clin Med; 1971 Nov; 78(5):797-8. PubMed ID: 5128833
    [No Abstract]   [Full Text] [Related]  

  • 33. Muscle and serum enzymes and isoenzymes in muscular dystrophies.
    Ibrahim GA; Zweber BA; Awad EA
    Arch Phys Med Rehabil; 1981 Jun; 62(6):265-9. PubMed ID: 7235920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum pyruvate kinase in muscle disease and carrier states.
    Alberts MC; Samaha FJ
    Neurology; 1974 May; 24(5):462-4. PubMed ID: 4857105
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D; Allen IV
    Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362
    [No Abstract]   [Full Text] [Related]  

  • 37. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable effects of corticosteroid treatment of serum enzyme activities in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Bozyk ME
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):529-38. PubMed ID: 70832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative utility of serum creatine kinase versus serum aldolase in the evaluation of muscle disorders.
    Giesker D; Bowers GN
    Conn Med; 1979 Nov; 43(11):699-704. PubMed ID: 389542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.